Tumor-targeted nano-drug delivery system capable of inducing copper death as well as preparation method and application of tumor-targeted nano-drug delivery system

By developing a tumor-targeted nanodrug delivery system that induces copper death, targeted liposomes are used to deliver copper ions to tumor tissues, targeted tumor therapy is achieved, and the toxicity and resistance of chemotherapy drugs to normal cells is solved, and the toxicity and drug resistance of chemotherapy drugs to normal cells is improved. Treatment effects and safety.

CN118892497APending Publication Date: 2024-11-05MATERNAL & CHILD HEALTH HOSPITAL OF INNER MONGOLIA AUTONOMOUS REGION
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410919585.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-10
Publication Date
2024-11-05

AI Technical Summary

Technical Problem

Existing chemotherapy drugs have killing effects on rapidly growing cells, and cannot distinguish between normal cells and tumor cells, leading to serious systemic toxic side effects, and are prone to tumor resistance, affecting prognosis, and urgently need new treatment strategies and tumor-targeted drug delivery system.

Method used

Develop a tumor-targeted nanodrug delivery system that induces copper death. Through copper ions-carrying liposomes, metal ion drugs are delivered to tumor tissues using targeting effects, combining passive targeting and active targeting to significantly improve delivery Efficiency and cell killing rate to achieve targeted tumor therapy.

Benefits of technology

Through dual targeting, it significantly improves the delivery efficiency and cell killing rate of metal ion drugs, reduces drug concentration in normal tissues, and reduces side effects, providing a new tumor suppression mechanism to overcome the systemic toxic side effects and drug resistance problems of traditional chemotherapy.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118892497A_ABST
    Figure CN118892497A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of biological medicines, and discloses a copper death-inducing tumor targeted nano-drug delivery system, which comprises the following raw materials by weight: 0.1-20 parts of neutral lipid, 0.01-5 parts of PEG lipid, 0.01-20 parts of a lipid material with a target head, 0.01-5 parts of copper salt, and the balance of water, and the total weight of the raw materials is 100 parts. According to the copper ion-coated liposome, namely the delivery system, the metal ion drug can be delivered to a tumor tissue part through a targeting effect, and the copper ion-coated liposome has the effects of chemical kinetics treatment and induction of tumor cell copper death and has the effect of synergistically treating tumors. The problem that metal ion drugs are difficult to target and concentrate in cancer cells can be solved, the tumor treatment effect is improved through multi-strategy synergistic treatment, and side effects are reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of biomedicine technology, and in particular to a tumor-targeted nano drug delivery system that induces copper death, and a preparation method and application thereof. Background Art

[0002] Cancer is the second leading cause of death worldwide. The common treatments for cancer are surgery or radiotherapy, plus chemotherapy. Chemotherapy drugs are cytotoxic drugs that kill fast-growing cells. They have serious systemic toxic side effects because they cannot distinguish between normal cells and tumor cells. They are also prone to tumor resistance, which affects prognosis. Therefore, new treatment strategies and tumor-targeted drug delivery are urgently needed to overcome the above problems of conventional chemotherapy.

[0003] Copper is an indispensable transition metal with redox properties. It provides or receives electrons as a cofactor for many enzymes in mitochondrial respiration, antioxidant defense, and biocompound synthesis. Copper is also an essential micronutrient and is of great significance in physiology and biochemistry. Its functions mainly include the following aspects: first, maintaining the health of the central nervous system, second, promoting the formation of connective tissue, third, promoting melanin production, and fourth, maintaining cardiovascular and cerebrovascular health. Copper in the human body, like many other elements, must be maintained at an appropriate level.

[0004] In the latest study, scientists reported a new type of cell death - copper death, that is, excessive accumulation of copper ions leads to abnormal aggregation of lipoyl proteins, interferes with iron-sulfur cluster proteins related to mitochondrial respiration, causes protein toxic stress response, and ultimately leads to cell death. The discovery of copper death, a new type of cell death, will further closely link transition metal ions represented by copper with tumor metabolism, provide new insights into the mechanism of copper-based anti-tumor drugs, and provide new strategies for the design of anti-tumor nanomaterials.

[0005] Liposomes are closed vesicles with a double layer (monolayer) and / or concentric multiple double layers (multilayers) of phospholipid bilayers to enclose the central water cavity, and water-soluble drugs can be encapsulated in the inner aqueous phase. The structure of liposomes is extremely similar to cell membranes, making them highly biocompatible and biodegradable, and the particle size of about 100 nm makes them passively targeted to solid tumors. If the liposomes are modified with target heads, active targeting is added on the basis of passive targeting, further improving tumor targeting, increasing drug concentration in tumor sites, reducing drug distribution in normal tissues, and playing a role in targeted therapy, toxicity reduction and synergistic effect. The preparation methods of liposomes include solvent injection method, thin film hydration method, reverse evaporation method, multiple emulsion method, and microfluidic method, among which thin film hydration method is the most classic method for preparing liposomes. Summary of the invention

[0006] The purpose of the present invention is to overcome the deficiencies in the prior art and provide a tumor-targeted nano drug delivery system that induces copper death and a preparation method and application thereof.

[0007] The technical solution adopted by the present invention to solve its technical problem is:

[0008] A tumor-targeted nano drug delivery system that induces copper death, the delivery system comprising the following raw materials in parts by weight:

[0009] 0.1-20 parts of neutral lipid, 0.01-5 parts of PEG lipid, 0.01-20 parts of lipid material with target head, 0.01-5 parts of copper salt, and the rest is water, and the total weight of all raw materials is 100 parts.

[0010] Furthermore, the neutral lipid is selected from one or more of PC, DSPC and DPPC.

[0011] Further, the PEG lipid is selected from DMG-PEG 2000 , DSPE-PEG 2000 One or more of .

[0012] Furthermore, the target head lipid material is selected from one or more of DSPE-PEG-Galactose, DSPE-PEG-RGD, DSPE-PEG-Folate, DSPE-PEG-Biotin, DSPE-PEG-RVG, and DSPE-PEG-ACA.

[0013] Furthermore, the copper salt is selected from one or more of copper chloride, copper acetate and copper sulfate.

[0014] The preparation method of the above-mentioned tumor-targeted nano drug delivery system that induces copper death comprises the following steps:

[0015] S1: neutral lipids, PEG lipids, and target lipid materials are dissolved in an organic solvent, and then rotary evaporated under reduced pressure to form a honeycomb film on the bottle wall;

[0016] S2 weighs copper salt and dissolves it in water to prepare a copper ion aqueous solution;

[0017] S3: adding copper ion aqueous solution to the film to hydrate it and dissolve all the honeycomb film on the bottle wall;

[0018] S4 ultrasonication or homogenization, filtering the whole particles, and preparing liposomes encapsulating copper ions;

[0019] S5 dialyzes the prepared liposomes to remove unencapsulated copper ions, thereby obtaining a tumor-targeted nanodrug delivery system that induces copper death.

[0020] Furthermore, the specific steps are as follows:

[0021] S1 weighed neutral lipids, PEG lipids, and target lipid materials and dissolved them in an organic solvent, and the organic solvent was removed by rotary evaporation under reduced pressure at 45°C-65°C to form a honeycomb film on the bottle wall;

[0022] S2 weighs copper salt and dissolves it in ultrapure water to prepare a copper ion aqueous solution;

[0023] S3: adding copper ion aqueous solution to the above film, hydrating at 45°C-65°C for 5-80 minutes to completely dissolve the honeycomb film on the bottle wall;

[0024] S4 ultrasonic or homogenized, and then filtered the whole particles through a 0.22 μm sterile filter membrane to obtain liposomes encapsulating copper ions;

[0025] S5 dialyzes the prepared liposomes, and the dialysate needs to be replaced three times with an interval of 30 minutes between each replacement, thereby obtaining a tumor-targeted nanodrug delivery system that induces copper death.

[0026] Furthermore, the duration of ultrasound in step S4 is 1-60 min, and the power is 5 W-600 W. Preferably, each ultrasound works for 1-2 s, with an interval of 1-2 s.

[0027] Furthermore, in step S4, the homogenization pressure is 5000 psi, and the cycle is repeated 2-10 times.

[0028] The application of the copper-death-inducing tumor-targeted nanodrug delivery system as described above in the preparation of tumor-targeted therapeutic drugs.

[0029] The advantages and positive effects achieved by the present invention are:

[0030] 1. The liposomes encapsulating copper ions of the present invention, i.e., the delivery system, can deliver metal ion drugs to tumor tissue sites through targeting, have chemodynamic therapy and induce copper death of tumor cells, and play a role in synergistic treatment of tumors. The present invention can solve the problem that metal ion drugs are difficult to target and concentrate in cancer cells, and improve the therapeutic effect of tumors and reduce side effects through multi-strategy synergistic treatment.

[0031] 2. The delivery system of the present invention uses dual targeting and membrane fusion pathways of liposome molecular bilayer membranes and cell membranes to deliver the drug to the cytoplasm, significantly improving the delivery efficiency and cell killing rate of metal ion drugs. The delivery system of the present invention is a drug delivery system that directly induces copper death, and uses a new therapeutic mechanism different from chemotherapy to suppress tumors.

[0032] 3. The present invention is based on the latest discovered cell death mode - copper death, and then develops a new tumor treatment therapy, and uses the new cell death mechanism for product development.

[0033] 4. The present invention successfully prepared a tumor-targeted nano-drug delivery system that induces copper death, that is, a liposome encapsulated with copper ions and modified with a target head for tumor targeted therapy. The liposome of the present invention can deliver copper ions to cancer tissues through passive targeting and active targeting, so that copper ions are concentrated in tumor tissues, thereby achieving the purpose of treating tumors.

[0034] 5. The delivery system of the present invention is a copper-induced death drug delivery system that has both passive tumor targeting and active tumor targeting effects, which plays a role in targeted killing of tumor cells while the drug concentration in normal tissues is low and the toxicity is low.

[0035] 6. The present invention is a tumor-targeted nano-drug delivery system that induces copper death based on the mechanism of cell copper death. By preparing liposomes of about 100 nm to encapsulate copper ions and modifying tumor-related target heads, it has an active targeting effect on the basis of the passive tumor targeting effect, that is, it has a dual targeting effect. By encapsulating copper ions in liposomes, it can promote their entry into cells through membrane fusion to induce copper death. The present invention uses a thin film dispersion method to prepare liposomes encapsulating copper ions, and performs post-treatment by dialysis to obtain copper ion liposomes with an encapsulation rate of more than 90%, uniform particle size distribution, rounded morphology and good stability. In view of the problem that traditional chemotherapy has large systemic toxic side effects and is prone to drug resistance, a corresponding tumor-targeted drug delivery system is developed based on the new tumor inhibition mechanism of copper death, which provides a new strategy for tumor treatment. BRIEF DESCRIPTION OF THE DRAWINGS

[0036] Figure 1 This is the particle size distribution diagram of the liposomes in Example 1 of the present invention;

[0037] Figure 2 This is the particle size distribution diagram of the liposomes in Example 2 of the present invention;

[0038] Figure 3 This is the particle size distribution diagram of the liposomes in Example 3 of the present invention;

[0039] Figure 4 This is the particle size distribution diagram of the liposomes in Example 4 of the present invention;

[0040] Figure 5 This is the particle size distribution diagram of the liposomes in Example 5 of the present invention;

[0041] Figure 6 This is the particle size distribution diagram of the liposomes in Example 6 of the present invention;

[0042] Figure 7This is the particle size distribution diagram of the liposomes in Comparative Example 1 of the present invention;

[0043] Figure 8 This is the particle size distribution diagram of the liposomes in Comparative Example 2 of the present invention;

[0044] Fig. 9 This is the particle size distribution diagram of the liposomes in Comparative Example 3 of the present invention;

[0045] Fig.10 This is a transmission electron microscope morphology image of Example 3 of the present invention;

[0046] Fig.11 This is a cell uptake image of Example 5 under a laser confocal microscope of the present invention;

[0047] Fig.12 This is a diagram showing the results of the MTT cytotoxicity experiment in Example 6 of the present invention. DETAILED DESCRIPTION

[0048] The present invention will be further described below in conjunction with the embodiments. The following embodiments are descriptive rather than restrictive, and the protection scope of the present invention cannot be limited by the following embodiments.

[0049] The various experimental operations involved in the specific embodiments are all routine techniques in the art. For parts not specially annotated in this document, ordinary technicians in the art can implement them by referring to various commonly used reference books, scientific and technological literature or related instructions, manuals, etc. before the filing date of this invention.

[0050] A tumor-targeted nano drug delivery system that induces copper death, the delivery system comprising the following raw materials in parts by weight:

[0051] 0.1-20 parts of neutral lipid, 0.01-5 parts of PEG lipid, 0.01-20 parts of lipid material with target head, 0.01-5 parts of copper salt, and the rest is water, and the total weight of all raw materials is 100 parts.

[0052] Preferably, the neutral lipid is selected from one or more of PC, DSPC and DPPC.

[0053] Preferably, the PEG lipid is selected from DMG-PEG 2000 , DSPE-PEG 2000 One or more of .

[0054] Preferably, the lipid material with a targeting head is selected from one or more of DSPE-PEG-Galactose, DSPE-PEG-RGD, DSPE-PEG-Folate, DSPE-PEG-Biotin, DSPE-PEG-RVG, and DSPE-PEG-ACA.

[0055] Preferably, the copper salt is selected from one or more of copper chloride, copper acetate and copper sulfate.

[0056] The preparation method of the above-mentioned tumor-targeted nano drug delivery system that induces copper death comprises the following steps:

[0057] S1: neutral lipids, PEG lipids, and target lipid materials are dissolved in an organic solvent, and then rotary evaporated under reduced pressure to form a honeycomb film on the bottle wall;

[0058] S2 weighs copper salt and dissolves it in water to prepare a copper ion aqueous solution;

[0059] S3: adding copper ion aqueous solution to the film to hydrate it and dissolve all the honeycomb film on the bottle wall;

[0060] S4 ultrasonication or homogenization, filtering the whole particles, and preparing liposomes encapsulating copper ions;

[0061] S5 dialyzes the prepared liposomes to remove unencapsulated copper ions, thereby obtaining a tumor-targeted nanodrug delivery system that induces copper death.

[0062] Preferably, the specific steps are as follows:

[0063] S1 weighed neutral lipids, PEG lipids, and target lipid materials and dissolved them in an organic solvent, and the organic solvent was removed by rotary evaporation under reduced pressure at 45°C-65°C to form a honeycomb film on the bottle wall;

[0064] S2 weighs copper salt and dissolves it in ultrapure water to prepare a copper ion aqueous solution;

[0065] S3: adding copper ion aqueous solution to the above film, hydrating at 45°C-65°C for 5-80 minutes to completely dissolve the honeycomb film on the bottle wall;

[0066] S4 ultrasonic or homogenized, and then filtered the whole particles through a 0.22 μm sterile filter membrane to obtain liposomes encapsulating copper ions;

[0067] S5 dialyzes the prepared liposomes, and the dialysate needs to be replaced three times with an interval of 30 minutes between each replacement, thereby obtaining a tumor-targeted nanodrug delivery system that induces copper death.

[0068] Preferably, the duration of ultrasound in step S4 is 1-60 min, and the power is 5 W-600 W. Preferably, each ultrasound operation lasts 1-2 s, with an interval of 1-2 s.

[0069] Preferably, the homogenization pressure in step S4 is 5000 psi, and the cycle is performed 2-10 times.

[0070] The application of the copper-death-inducing tumor-targeted nanodrug delivery system as described above in the preparation of tumor-targeted therapeutic drugs.

[0071] Specifically, the relevant preparation and detection are as follows:

[0072] Example 1

[0073] A method for preparing a copper ion-encapsulated liposome, i.e., a tumor-targeted nano drug delivery system that induces copper death, comprises the following steps:

[0074] PC:DMG-PEG 2000 :DSPE-PEG-Galactose=5:1:0.5 (mass ratio) To prepare liposomes encapsulating copper ions, cupric chloride dihydrate was weighed and added into ultrapure water to prepare a 10 mg / ml aqueous solution.

[0075] Weigh PC and DMG-PEG in proportion 2000 DSPE-PEG-Galactose was dissolved in 2 mL of chloroform, and the organic solvent was removed by rotary evaporation at 55°C to form a honeycomb film on the bottle wall; then, a cupric chloride aqueous solution was added to hydrate at 55°C for 40 min; then, the liposomes were transferred to a test tube, and the liposomes were ultrasonically treated in an ice bath for 5 min using an ultrasonic cell crusher probe (10 W, working for 2 s, and interval for 2 s), and then the whole particles were filtered through a 0.22 μm sterile filter membrane to obtain copper ion-encapsulated liposomes, and the obtained liposomes were dialyzed. The liposome particle size distribution is shown in Figure 1 .

[0076] Example 2

[0077] A method for preparing a copper ion-encapsulated liposome, i.e., a tumor-targeted nano drug delivery system that induces copper death, comprises the following steps:

[0078] PC:DMG-PEG 2000 :DSPE-PEG-Galactose=4:1:0.5 (mass ratio) To prepare liposomes encapsulating copper ions, cupric chloride dihydrate was weighed and added into ultrapure water to prepare a 10 mg / ml aqueous solution.

[0079] Weigh PC and DMG-PEG in proportion 2000DSPE-PEG-Galactose was dissolved in 2 mL of chloroform, and the organic solvent was removed by rotary evaporation at 55°C to form a honeycomb film on the bottle wall; then, a cupric chloride aqueous solution was added to hydrate at 55°C for 40 min; then, the liposomes were transferred to a test tube, and the liposomes were ultrasonically treated in an ice bath for 5 min using an ultrasonic cell crusher probe (10 W, working for 2 s, and interval for 2 s), and then the whole particles were filtered through a 0.22 μm sterile filter membrane to obtain copper ion-encapsulated liposomes, and the obtained liposomes were dialyzed. The liposome particle size distribution is shown in Figure 2 .

[0080] Example 3

[0081] A method for preparing a copper ion-encapsulated liposome, i.e., a tumor-targeted nano drug delivery system that induces copper death, comprises the following steps:

[0082] PC:DMG-PEG 2000 :DSPE-PEG-Galactose=3:1:0.5 (mass ratio) To prepare liposomes encapsulating copper ions, cupric chloride dihydrate was weighed and added into ultrapure water to prepare a 10 mg / ml aqueous solution.

[0083] Weigh PC and DMG-PEG in proportion 2000 DSPE-PEG-Galactose was dissolved in 2 mL of chloroform, and the organic solvent was removed by rotary evaporation at 55°C to form a honeycomb film on the bottle wall; then, a cupric chloride aqueous solution was added to hydrate at 55°C for 40 min; then, the liposomes were transferred to a test tube, and the liposomes were ultrasonically treated in an ice bath for 5 min using an ultrasonic cell crusher probe (10 W, working for 2 s, and interval for 2 s), and then the whole particles were filtered through a 0.22 μm sterile filter membrane to obtain copper ion-encapsulated liposomes, and the obtained liposomes were dialyzed. The liposome particle size distribution is shown in Figure 3 .

[0084] Example 4

[0085] A method for preparing a copper ion-encapsulated liposome, i.e., a tumor-targeted nano drug delivery system that induces copper death, comprises the following steps:

[0086] PC:DMG-PEG 2000 :DSPE-PEG-Galactose=4:1:0.5 (mass ratio) To prepare liposomes encapsulating copper ions, copper chloride dihydrate was weighed and added to ultrapure water to prepare a 10 mg / ml aqueous solution. Cy5.5 dye was added to the prepared copper chloride aqueous solution.

[0087] Weigh PC and DMG-PEG in proportion 2000DSPE-PEG-Galactose was dissolved in 2 mL of chloroform, and the organic solvent was removed by rotary evaporation under reduced pressure at 55°C to form a honeycomb film on the bottle wall; then, a cupric chloride aqueous solution was added to hydrate at 55°C for 40 min (all protected from light); then, the liposomes were transferred to a test tube, and the liposomes were sonicated in an ice bath using an ultrasonic cell crusher probe for 6 min (10 W, working for 2 s, interval for 2 s), and then the whole particles were filtered through a 0.22 μm sterile filter membrane to obtain copper ion-loaded liposomes, and the prepared liposomes were dialyzed. The liposome particle size distribution is shown in Figure 4 .

[0088] Example 5

[0089] A method for preparing a copper ion-encapsulated liposome, i.e., a tumor-targeted nano drug delivery system that induces copper death, comprises the following steps:

[0090] PC:DMG-PEG 2000 :DSPE-PEG-Galactose=4:1:0.5 (mass ratio) To prepare liposomes encapsulating copper ions, cupric chloride dihydrate was weighed and added into ultrapure water to prepare a 10 mg / ml aqueous solution.

[0091] Weigh PC and DMG-PEG in proportion 2000 , DSPE-PEG-Galactose was dissolved in 2 mL of anhydrous ethanol, and the fat-soluble dye Cou-6 was added, and the organic solvent was removed by rotary evaporation under reduced pressure at 55°C to form a honeycomb film on the bottle wall; then, a cupric chloride aqueous solution was added to hydrate at 55°C for 40 minutes; then the liposomes were transferred to a test tube, and the liposomes were ultrasonically treated with an ultrasonic cell crusher probe in an ice bath for 7 minutes (10W, working 2s, interval 2s), and then the whole particles were filtered through a 0.22μm sterile filter membrane to obtain copper ion-encapsulated liposomes, and the prepared liposomes were dialyzed, and the liposome particle size distribution was shown in Figure 5 .

[0092] Example 6

[0093] A method for preparing a copper ion-encapsulated liposome, i.e., a tumor-targeted nano drug delivery system that induces copper death, comprises the following steps:

[0094] PC:DMG-PEG 2000 :DSPE-PEG-Galactose=4:1:0.5 (mass ratio) was used to prepare liposomes encapsulating copper ions, and Cy5.5 dye was added to 5 ml of ultrapure water.

[0095] Weigh PC and DMG-PEG in proportion 2000DSPE-PEG-Galactose was dissolved in 2 mL of chloroform, and the organic solvent was removed by rotary evaporation under reduced pressure at 55°C to form a honeycomb film on the bottle wall; then the hydration solution was added and hydrated at 55°C for 40 min (all protected from light); then the liposomes were transferred to a test tube, and the liposomes were sonicated in an ice bath using an ultrasonic cell crusher probe for 7 min (10 W, working for 2 s, interval for 2 s), and then the whole particles were filtered through a 0.22 μm sterile filter membrane to obtain copper ion-encapsulated liposomes. The particle size distribution of the liposomes is shown in FIG. Figure 6 .

[0096] Comparative Example 1

[0097] Preparation of liposomes loaded with copper ions:

[0098] PC was used to prepare liposomes loaded with copper ions. Copper chloride dihydrate was weighed and added to ultrapure water to prepare a 10 mg / ml aqueous solution. PC was weighed as needed and dissolved in 2 mL of anhydrous ethanol and the organic solvent was removed by rotary evaporation at 55°C under reduced pressure to form a honeycomb film on the bottle wall. Then, copper chloride aqueous solution was added and hydrated at 55°C for 50 minutes. Then, the liposomes were transferred to a test tube, and the liposomes were ultrasonically treated with an ultrasonic cell crusher probe in an ice bath for 7 minutes (10 W, working for 2 seconds, and intervals of 2 seconds). Then, the whole particles were filtered through a 0.22 μm sterile filter membrane to obtain copper ion-loaded liposomes. The prepared liposomes were dialyzed, and the liposome particle size distribution was shown in FIG. Figure 7 .

[0099] Comparative Example 2

[0100] Preparation of liposomes loaded with copper ions:

[0101] PC:DMG-PEG 2000 =3:1 (mass ratio) to prepare liposomes encapsulating copper ions, weigh copper chloride dihydrate and add ultrapure water to prepare a 10 mg / ml aqueous solution. Weigh PC as needed and dissolve it in 3 mL of anhydrous ethanol, remove the organic solvent by rotary evaporation at 55°C under reduced pressure, and form a honeycomb film on the bottle wall; then add copper chloride aqueous solution and hydrate at 55°C for 50 minutes; then transfer the liposomes to a test tube, use an ultrasonic cell crusher probe to ultrasonically treat the liposomes in an ice bath for 7 minutes (10W, working 2s, interval 2s), and then filter the whole particles through a 0.22μm sterile filter membrane to obtain copper ion encapsulating liposomes, and dialyze the prepared liposomes. The liposomes have a particle size distribution as shown in Figure 8 .

[0102] Comparative Example 3

[0103] Preparation of liposomes loaded with copper ions:

[0104] DSPC:DMG-PEG 2000=4:1 (mass ratio) to prepare liposomes encapsulating copper ions, weigh copper chloride dihydrate and add ultrapure water to prepare a 10 mg / ml aqueous solution. Weigh DSPC, DMG-PEG according to the proportion 2000 Dissolved in 3 mL of anhydrous ethanol, the organic solvent was removed by rotary evaporation at 55°C under reduced pressure to form a honeycomb film on the bottle wall; then copper chloride aqueous solution was added to hydrate at 55°C for 40 minutes; then the liposomes were transferred to a test tube, and the liposomes were ultrasonically treated with an ultrasonic cell crusher probe in an ice bath for 7 minutes (10W, working 2s, interval 2s), and then the whole particles were filtered through a 0.22μm sterile filter membrane to obtain copper ion-encapsulated liposomes. The prepared liposomes were dialyzed, and the liposome particle size distribution was shown in Fig. 9 .

[0105] Test Example 1

[0106] After the samples of Example 1, Example 2, Example 3, Example 4, Example 5, Example 6, Comparative Example 1, Comparative Example 2 and Comparative Example 3 were diluted to an appropriate multiple, the particle size of the liposomes was analyzed at room temperature using a Malvern Nano-ZS 90 laser particle size analyzer. The measurement results are shown in Table 1. It can be seen that the liposome particle size obtained by changing the lipid component ratio in Example 1, Example 2 and Example 3 is normally distributed, the median diameter is about 90-100nm, the polymer dispersibility index PDI is below 0.2, and the liposome particle size distribution is uniform and has high stability. In Example 4 and Example 5, by changing the ultrasonic time, the liposome particle size is about 96-98nm, the PDI is about 0.13-0.17, the liposome particle size distribution is uniform, and the stability is high. It can be seen that the preparation process of the above embodiments has good preparation effects. In Example 6 and Example 5, the organic solvent for dissolving lipid materials was changed, and the particle size distribution of the prepared liposomes was good, indicating that ethanol or chloroform can be used as an organic solvent to dissolve lipid materials in the process of preparing liposomes by thin film dispersion method; at the same time, the fat-soluble dye Cou-6 was added in Example 5, and the water-soluble dye Cy5.5 was added in Example 6, indicating that the addition of these two dyes with different solubility had no significant effect on the particle size of the liposomes. In Comparative Examples 1, 2, and 3, by using different lipid formulations without adding target heads, the liposomes prepared had a larger particle size than the liposomes prepared by the above-mentioned experimental example preparation process, the PDI was above 0.2, and the liposome stability was poor. It can be seen that the addition of the target head enhances the stability of the liposomes.

[0107] Table 1 Particle size and PDI measurement results

[0108]

[0109]

[0110] Test Example 2

[0111] 100 μL of the sample solution prepared in Example 3 and Example 4 was added with ultrapure water and diluted to 1000 times, and the content of copper ions was measured by inductively coupled plasma mass spectrometry. The results are shown in Table 2. It can be concluded that the liposome copper ion encapsulation rate of Example 3 and Example 4 is above 90%, achieving good encapsulation.

[0112] Table 2 Encapsulation efficiency determination results

[0113] Total copper ion content (μg) Total content of dialysate (μg) Encapsulation rate (%) Example 3 1265 92.3 92.70 Example 4 1415 82.7 94.15

[0114] Test Example 3

[0115] Morphological observation by transmission electron microscopy (TEM):

[0116] Take the copper mesh, add 20 μL of the liposome prepared in Example 1, wait for the sample to air dry naturally, then add 20 μL of 2% phosphotungstic acid to negatively stain the adsorbed sample for 3 seconds, then use filter paper to absorb the excess dye, and observe the microscopic morphology of the liposomes encapsulating copper ions by TEM after drying. Fig.10 It can be seen that the liposomes prepared in Example 1 are uniformly dispersed spherical.

[0117] Test Example 4

[0118] Cellular uptake assay:

[0119] Laser confocal inverted fluorescence microscopy was used to characterize the effect of HepG2 cells taking up copper ion-encapsulated liposomes. HpeG2 cells in the logarithmic growth phase were cultured at 1×10 4 The cells were inoculated at a density of cells / mL in a confocal culture dish and cultured for 24 hours at 37°C, 5% CO2, and 90% humidity. 50 μL of the product prepared in Example 5 was added to each well, and then the dish was placed in an incubator for 4 hours. After 4 hours, the culture medium was aspirated, PBS was added to wash three times, and paraformaldehyde solution was added to fix for 10 minutes. The liquid in the dish was aspirated, PBS was added to wash three times, the liquid in the dish was aspirated, 1 ml of 2 μg / ml DAPI was added, the liquid in the dish was aspirated, PBS was added to wash three times, and 1-2 ml of PBS was added to observe the cell uptake under a laser confocal microscope. Fig.11 It can be seen that liposomes can enter cells through membrane fusion pathway (showing green fluorescence) and have good cell uptake ability.

[0120] Test Example 5

[0121] MTT assay:

[0122] HepG2 cells in logarithmic growth phase were cultured at 2×10 4The cells were inoculated into a 96-well cell culture plate at a density of cells / mL. After culturing for 24 hours, different concentrations of Example 6 (i.e., the stock solution group) and a solution with the same copper ion concentration (i.e., the copper ion group) were added, and 6 replicate wells were set. After incubation for 48 hours under normal conditions, 20 μL MTT (5 mg / mL) solution was added to each well under light-proof conditions. After 4 hours of light-proofing, the culture medium in the well was aspirated and 100 μL DMSO was added to dissolve the formazan crystals. The absorbance was measured at 492 nm and 630 nm using an ELISA reader. The results are shown in Table 1. Fig.12 It can be seen that the cell killing effect of the copper ion group is weak, with a cell survival rate of 70.5%, but the cell killing effect of Example 6 at the same concentration is extremely strong, with a cell survival rate of only 24.8%. After being diluted 5 times, the cell survival rate still reaches 46.7%, indicating that after the copper ions are encapsulated by liposomes, they are promoted to enter the cells through membrane fusion, and can exert a stronger cell killing effect.

[0123] Although the embodiments of the present invention are disclosed for illustrative purposes, those skilled in the art will appreciate that various substitutions, changes and modifications are possible without departing from the spirit and scope of the present invention and the appended claims. Therefore, the scope of the present invention is not limited to the contents disclosed in the embodiments.

Claims

1. A tumor-targeted nanodrug delivery system that induces copper death, characterized in that: The delivery system comprises the following raw materials in parts by weight: 0.1-20 parts of neutral lipid, 0.01-5 parts of PEG lipid, 0.01-20 parts of lipid material with target head, 0.01-5 parts of copper salt, and the rest is water, and the total weight of all raw materials is 100 parts.

2. The tumor-targeted nano drug delivery system that induces copper death according to claim 1, characterized in that: The neutral lipid is selected from one or more of PC, DSPC and DPPC.

3. The tumor-targeted nano drug delivery system that induces copper death according to claim 1, characterized in that: The PEG lipid is selected from DMG-PEG 2000 , DSPE-PEG 2000 One or more of .

4. The tumor-targeted nano drug delivery system that induces copper death according to claim 1, characterized in that: The target head lipid material is selected from one or more of DSPE-PEG-Galactose, DSPE-PEG-RGD, DSPE-PEG-Folate, DSPE-PEG-Biotin, DSPE-PEG-RVG, and DSPE-PEG-ACA.

5. The tumor-targeted nano drug delivery system that induces copper death according to any one of claims 1 to 4, characterized in that: The copper salt is selected from one or more of copper chloride, copper acetate and copper sulfate.

6. The method for preparing the tumor-targeted nano drug delivery system that induces copper death according to any one of claims 1 to 5, characterized in that: The steps include: S1: neutral lipids, PEG lipids, and target lipid materials are dissolved in an organic solvent, and then rotary evaporated under reduced pressure to form a honeycomb film on the bottle wall; S2 weighs copper salt and dissolves it in water to prepare a copper ion aqueous solution; S3: adding copper ion aqueous solution to the film to hydrate it and dissolve all the honeycomb film on the bottle wall; S4 ultrasonication or homogenization, filtering the whole particles, and preparing liposomes encapsulating copper ions; S5 dialyzes the prepared liposomes to remove unencapsulated copper ions, thereby obtaining a tumor-targeted nanodrug delivery system that induces copper death.

7. The preparation method according to claim 6, characterized in that: The specific steps are as follows: S1 weighed neutral lipids, PEG lipids, and target lipid materials and dissolved them in an organic solvent, and the organic solvent was removed by rotary evaporation under reduced pressure at 45°C-65°C to form a honeycomb film on the bottle wall; S2 weighs copper salt and dissolves it in ultrapure water to prepare a copper ion aqueous solution; S3: adding copper ion aqueous solution to the above film, hydrating at 45°C-65°C for 5-80 minutes to completely dissolve the honeycomb film on the bottle wall; S4 ultrasonic or homogenized, and then filtered the whole particles through a 0.22 μm sterile filter membrane to obtain liposomes encapsulating copper ions; S5 dialyzes the prepared liposomes, and the dialysate needs to be replaced three times with an interval of 30 minutes between each replacement, thereby obtaining a tumor-targeted nanodrug delivery system that induces copper death.

8. The preparation method according to claim 6 or 7, characterized in that: The duration of ultrasound in step S4 is 1-60 min, and the power is 5 W-600 W. Preferably, each ultrasound works for 1-2 s, with an interval of 1-2 s.

9. The preparation method according to claim 6 or 7, characterized in that: The homogenization pressure in step S4 is 5000 psi, and the cycle is repeated 2-10 times.

10. Use of the tumor-targeted nano drug delivery system that induces copper death as claimed in any one of claims 1 to 5 in the preparation of tumor-targeted therapeutic drugs.